Keyphrases
Resectable Lung Cancer
100%
Lymph Node Involvement
100%
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Mediastinal Lymph Nodes
100%
Confidence Interval
31%
Estimation Accuracy
31%
SUVmax
25%
Sensitivity Analysis
18%
Non-small Cell Lung Cancer (NSCLC)
18%
Diagnostic Accuracy
12%
Malignancy
12%
Index Tests
12%
Summary Receiver Operating Characteristic
12%
Receiver Operating Characteristic
12%
Computed Tomography Scanner
12%
Characteristic Space
12%
Confidence Region
12%
Prediction Region
12%
Between-study Variance
12%
Positive Criteria
12%
Test Positivity
12%
Fluorodeoxyglucose
12%
Funding Bias
12%
Commercial Finance
12%
Lung Cancer
6%
Treatment Choice
6%
Lymph Node
6%
Search Methods
6%
Adverse Events
6%
Inflammatory Diseases
6%
Accurate Staging
6%
MEDLINE
6%
Cochrane Library
6%
Meta-analysis
6%
Embase
6%
Major Determinants
6%
Nodal Status
6%
Selection Criteria
6%
Adenocarcinoma
6%
Quality Assessment
6%
Operating Point
6%
Treatment Decisions
6%
Low Risk
6%
Surgery Resection
6%
Infectious Diseases
6%
Extracted Data
6%
Incidence Rate
6%
Selection Bias
6%
Overall Accuracy
6%
Retrospective Longitudinal Study
6%
Curative Intent
6%
Publication Year
6%
Decision Basis
6%
Optimal Treatment
6%
National Institutes of Health
6%
Clinical Excellence
6%
Staging Procedures
6%
Characteristic Model
6%
Hierarchical Summary
6%
Group Activity
6%
Publication Status
6%
Language Status
6%
Risk of Bias
6%
QUADAS-2
6%
Tuberculosis Incidence
6%
ProQuest
6%
Mediastinal Staging
6%
N2 Disease
6%
Heterogeneity Analysis
6%
Bias Study
6%
Lower Estimate
6%
Standardized Uptake Value
6%
Noninvasive Staging
6%
Cancer multidisciplinary Team
6%
Mediastinal Nodes
6%
Test Bias
6%
Attenuation Correction
6%
Reliable Decision
6%
Lung Cancer Subtype
6%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Positron Emission Tomography-Computed Tomography
100%
Mediastinal Lymph Node
100%
Sensitivity and Specificity
43%
Prevalence
18%
Diseases
18%
Diagnostic Accuracy
12%
Cancer
12%
Study Heterogeneity
12%
Clinician
6%
Inflammatory Disorder
6%
Biopsy Technique
6%
Cross Sectional Study
6%
Meta-Analysis
6%
Adverse Event
6%
Lymph Node
6%
Lung Cancer
6%
Population Research
6%
Adenocarcinoma
6%
False Negative Result
6%
Selection Bias
6%
Infectious Disease
6%
False Positive Result
6%
Fluorine-18
6%
Standardized Uptake Value
6%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Diseases
80%
Prevalence
60%
Lung Cancer
20%
Cross-Sectional Study
20%
Adverse Event
20%
Adenocarcinoma
20%
Fluorine 18
20%
Population Study
20%